---
title: "Deutsche Bank  Keeps Their Buy Rating on Sanofi (SNYNF)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289749184.md"
description: "Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Sanofi (SNYNF) with a €95.00 price target. Papadakis, a 4-star analyst covering healthcare stocks including AstraZeneca and GSK, has a 3.6% average return. Additionally, Jefferies maintained a Buy rating on the stock with a higher €100.00 price target in a June 4 report."
datetime: "2026-06-15T07:55:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289749184.md)
  - [en](https://longbridge.com/en/news/289749184.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289749184.md)
generator: "portal-rs"
---

# Deutsche Bank  Keeps Their Buy Rating on Sanofi (SNYNF)

Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Sanofi today and set a price target of €95.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions.
-   Discover top stock picks and new investment opportunities through TipRanks' Smart Investor Newsletter.

According to TipRanks, Papadakis is a 4-star analyst with an average return of 3.6% and a 52.63% success rate. Papadakis covers the Healthcare sector, focusing on stocks such as AstraZeneca, GlaxoSmithKline, and Sanofi.

In a report released on June 4, Jefferies also maintained a Buy rating on the stock with a €100.00 price target.

### Related Stocks

- [SNYNF.US](https://longbridge.com/en/quote/SNYNF.US.md)
- [SNY.US](https://longbridge.com/en/quote/SNY.US.md)
- [DB.US](https://longbridge.com/en/quote/DB.US.md)
- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [GSK.US](https://longbridge.com/en/quote/GSK.US.md)
- [JEF.US](https://longbridge.com/en/quote/JEF.US.md)
- [DBK.DE](https://longbridge.com/en/quote/DBK.DE.md)
- [03KB.DE](https://longbridge.com/en/quote/03KB.DE.md)
- [DPB.DE](https://longbridge.com/en/quote/DPB.DE.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [GSK.UK](https://longbridge.com/en/quote/GSK.UK.md)
- [GSK.WI.US](https://longbridge.com/en/quote/GSK.WI.US.md)

## Related News & Research

- [Sanofi (ENXTPA:SAN) Halted Its Phase 3 RSV Vaccine Trial](https://longbridge.com/en/news/297413868.md)
- [Novavax Partners Receive Approvals For Nuvaxovid Formulation To Target Covid Variant](https://longbridge.com/en/news/297333166.md)
- [Vaxcyte management to join Wells Fargo healthcare conference fireside chat](https://longbridge.com/en/news/297227027.md)
- [Attovia Therapeutics, Inc. (ATTO) Initiated with a Buy at RBC Capital](https://longbridge.com/en/news/297470988.md)
- [Piper Sandler Sticks to Its Hold Rating for Agilent (A)](https://longbridge.com/en/news/297181196.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**